We are very grateful to the funding bodies who support our work, the British Heart Foundation and the Wellcome Trust.

We are also grateful to the non-malignant haematology NIHR subgroup (chaired by Dr Peter Collins, Cardiff) and the Lead Network service provided by Birmingham and the Black Country Comprehensive Local Research Network.

GAPP is listed on the NIHR non-malignant haematology portfolio (ID 9858) and is co-adopted into the primary care portfolio.